TITLE

Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans

AUTHOR(S)
Freedman, Barry I.; Hicks, Pamela J.; Bostrom, Meredith A.; Cunningham, Mary E.; Yongmei Liu; Divers, Jasmin; Kopp, Jeffrey B.; Winkler, Cheryl A.; Nelson, George W.; Langefeld, Carl D.; Bowden, Donald W.
PUB. DATE
April 2009
SOURCE
Kidney International;Apr2009, Vol. 75 Issue 7, p736
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
African Americans have high incidence rates of end-stage renal disease (ESRD) labeled as due to hypertension. As recent studies showed strong association with idiopathic and HIV-related focal segmental glomerulosclerosis and non-muscle myosin heavy chain 9 (MYH9) gene polymorphisms in this ethnic group, we tested for MYH9 associations in a variety of kidney diseases. Fifteen MYH9 single-nucleotide polymorphisms were evaluated in 175 African Americans with chronic glomerulonephritis-associated ESRD, 696 African Americans reportedly with hypertension-associated ESRD, and 948 control subjects without kidney disease. Significant associations were detected with 14 of the 15 polymorphisms in all 871 non-diabetic patients with ESRD. In hypertension-associated ESRD cases alone, significant associations were found with 13 MYH9 polymorphisms and the previously reported E1 haplotype. Thus, hypertension-associated ESRD in African Americans is substantially related to MYH9 gene polymorphisms and this may explain the poor response to blood pressure control in those diagnosed with hypertensive nephrosclerosis. It is possible that many African Americans classified as having hypertension-associated ESRD have occult MYH9-associated segmental or global glomerulosclerosis. Our study shows that gene-environment and/or gene–gene interactions may initiate kidney disease in genetically susceptible individuals, because African Americans homozygous for MYH9 risk alleles do not universally develop kidney disease.Kidney International (2009) 75, 736–745; doi:10.1038/ki.2008.701; published online 28 January 2009
ACCESSION #
36893233

 

Related Articles

  • Renin gene rs1464816 polymorphism contributes to chronic kidney disease progression in ADPKD. Ramanathan, Gnanasambandan; Elumalai, Ramprasad; Periyasamy, Soundararajan; Lakkakula, Bhaskar V. K. S. // Journal of Biomedical Science;1/11/2016, Vol. 23, p1 

    Background: Autosomal dominant polycystic kidney disease (ADPKD) is a monogenic disorder and is a common genetic cause of chronic renal failure in children and adults. The enzyme renin plays a key role in the RAAS cascade and an important role in the development of hypertension and progression...

  • Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats. Ayinuer Adijiang; Sumie Goto; Satsuki Uramoto; Fuyuhiko Nishijima; Toshimitsu Niwa // Nephrology Dialysis Transplantation;Jun2008, Vol. 23 Issue 6, p1892 

    Background. Stage 5 chronic kidney disease (CKD) is associated with enhanced aortic calcification. The aim of this study was to determine if the administration of indoxyl sulphate (IS), a uraemic toxin, stimulates the progression of aortic calcification. Methods. The rat groups consisted of (i)...

  • The Quiet Killer. O. Z., Mehmet // O, The Oprah Magazine;Oct2010, Vol. 11 Issue 10, p154 

    In this article, the author reports on chronic kidney disease (CKD), a life-threatening disease that afflicts millions of people in the U.S. CKD occurs when over the course of several months to years, the organs' tiny filters are progressively damaged. Diabetes and hypertension, together account...

  • Genome Study of Kidney Disease in the Age of Post Genome-Sequencing. Doi, Kent; Okamoto, Koji; Tokunaga, Katsushi; Fujita, Toshiro; Noiri, Eisei // Endocrine, Metabolic & Immune Disorders - Drug Targets;Sep2008, Vol. 8 Issue 3, p173 

    The genome-based study of human disease has been developing rapidly with the completion of the human genome project and the remarkable progress of technology. The genetic variation information associated with disease will certainly enable us to discover potential drug targets and to develop...

  • Hypertension and albuminuria in chronic kidney disease mapped to a mouse chromosome 11 locus. Salzler, H. R.; Griffiths, R.; Ruiz, P.; Chi, L.; Frey, C.; Marchuk, D. A.; Rockman, H. A.; Le, T. H. // Kidney International;Nov2007, Vol. 72 Issue 10, p1226 

    Chronic kidney disease (CKD) is a key cause of hypertension and a potent independent risk for cardiovascular disease. Epidemiological studies suggest a strong genetic component determining susceptibility for renal disease and, by inference, the associated cardiovascular risk. With a subtotal...

  • Endogenous digitalis-like factors in hypertension and chronic renal insufficiency. Kelly, Ralph A.; O'Hara, Donald S.; Mitch, William E.; Steinman, Theodore I.; Goldszer, Robert C.; Solomon, Harold S.; Smith, Thomas W. // Kidney International;Nov1986, Vol. 30 Issue 5, p723 

    Endogenous digitalis—like factors have been implicated in the adaptations that accompany renal insufficiency and in the pathogenesis of hypertension. We recently described several fractions of normal human plasma that inhibit NaK-ATPase and exhibit apparent digoxin-like immunoreactivity....

  • Systemic and glomerular hypertension and progression of chronic renal disease: The dilemma of nephrosclerosis. Marín, Rafael; Gorostidi, Manuel; Fernández-Vega, Francisco; Álvarez-Navascués, Rafael // Kidney International Supplement;Dec2005, Issue 99, pS52 

    The link between the kidney and hypertension has been considered a villain-victim relationship. High blood pressure levels are a well-recognized feature in chronic renal disease, but the ability of mild-to-moderate hypertension to produce renal insufficiency has been questioned. Nephrosclerosis,...

  • Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease. Baboolal, Keshwar; Ravine, David; Daniels, Joe; Williams, Nigel; Holmans, Peter; Coles, Gerald A.; Williams, John D. // Kidney International;Sep1997, Vol. 52 Issue 3, p607 

    Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRE in PKDI adult pulycystic kidney disease. To determine the effect of the ACE gene insertion/deletion (I/D) polymorphism, angiotensinogen gene M235T polymorphism and the...

  • IgA nephropathy in identical twins: an excellent donor and recipient outcome 11 years after transplantation. Irvine, John; Cross, Nicholas; Lynn, Kelvin; Robson, Richard; Searle, Martin; Morton, John; Armstrong, Sarah; Roake, Justin // Clinical Kidney Journal;Jun2012, Vol. 5 Issue 3, p232 

    We present a case of IgA nephropathy (IgAN) in monozygotic twins with excellent donor and recipient outcome 11 years after transplantation. The recipient developed IgAN at 26 years and progressed to end-stage renal failure 10 years later. His identical twin who had hypertension, intermittent...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics